Oncogenic Role of Tumor Viruses in Humans

被引:78
|
作者
Akram, Nimrah [1 ]
Imran, Muhammad [1 ]
Noreen, Mamoona [2 ]
Ahmed, Fayyaz [1 ]
Atif, Muhammad [1 ]
Fatima, Zareen [3 ]
Waqar, Ahmed Bilal [1 ]
机构
[1] ICBS, FHAS, DMLS, Lahore 54000, Pakistan
[2] Women Univ Multan, Dept Zool, Multan, Pakistan
[3] ICBS, FHAS, DRSMI, Lahore, Pakistan
关键词
cellular immunity; epidemiology; immunomodulators; host-virus; interactions; resistance; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; T-CELL LEUKEMIA; KAPOSIS-SARCOMA; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; GASTRIC-CARCINOMA; NUCLEAR ANTIGEN; HUMAN CANCERS;
D O I
10.1089/vim.2016.0109
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viruses are the intracellular pathogens that reproduce only in the living cell and manipulate the cellular machinery to produce more viruses. Viral replications can affect cellular genes of the host in multiple cancerous ways. Approximately, 20% of all human oncogenesis is caused by cancer-causing viruses known as oncoviruses. Viral infection causes chronic inflammation leading to cell death, uncontrollable proliferation, and modulated expression of some of the regulatory proteins. Oncogenesis is a multistep phenomenon in which normal host cells are transformed into cancerous cells on the basis of host genetic variability. Oncogenic viruses encode genes that cause viral replication and transformation of the host cells to produce viral proteins and protein complexes. The phenomenon from basic viral infection to tumorigenesis is lengthy due to the involvement of factors like immunity complications, cellular mutations, and exposure to other cancerous agents. The viruses that are involved in human cancer development are Hepatitis B virus (HBV), Hepatitis C virus (HCV), Epstein-Barr virus (EBV), Human papilloma virus (HPV), Kaposi's sarcoma herpes virus (KSHV), and Human T lymphotrophic virus 1 (HTLV-1). This review article summarizes advanced knowledge related to human oncogenic viruses and the molecular mechanisms that lead to tumorigenesis in humans.
引用
收藏
页码:20 / 27
页数:8
相关论文
共 50 条
  • [21] Role of oncogenic viruses in the development ocular surface squamous neoplasia
    Shirin Hamed-Azzam
    Natalia Edison
    Daniel Briscoe
    Shahar Frenkel
    Abed Mukari
    Meirav Strauss
    Hector Camacho
    Irit Elmalah
    Judit Krausz
    International Ophthalmology, 2021, 41 : 3599 - 3605
  • [22] Oncogenic Viruses and Tumor Glucose Metabolism: Like Kids in a Candy Store
    Noch, Evan
    Khalili, Kamel
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (01) : 14 - 23
  • [23] A Review of Mitochondrial Involvement in Cell Death Pathways Induced by Oncogenic Viruses
    Abyar, Sahel
    Shoraka, Shahrzad
    Hosseini, Seyed Masoud
    Zali, Mohammad Reza
    Mohebbi, Seyed Reza
    BIOCELL, 2025, 49 (02) : 221 - 251
  • [24] Oncogenic virus-mediated cell fusion: New insights into initiation and progression of oncogenic viruses-related cancers
    Gao, Peng
    Zheng, Jie
    CANCER LETTERS, 2011, 303 (01) : 1 - 8
  • [25] Tumor viruses and cancer biology Modulating signaling pathways for therapeutic intervention
    Saha, Abhik
    Kaul, Rajeev
    Murakami, Masanao
    Robertson, Erle S.
    CANCER BIOLOGY & THERAPY, 2010, 10 (10) : 961 - 978
  • [26] Plasmid Partitioning by Human Tumor Viruses
    Chiu, Ya-Fang
    Sugden, Bill
    JOURNAL OF VIROLOGY, 2018, 92 (09)
  • [27] Interaction of Human Tumor Viruses with Host Cell Surface Receptors and Cell Entry
    Schaefer, Georgia
    Blumenthal, Melissa J.
    Katz, Arieh A.
    VIRUSES-BASEL, 2015, 7 (05): : 2592 - 2617
  • [29] Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development
    Vescovo, Tiziana
    Pagni, Benedetta
    Piacentini, Mauro
    Fimia, Gian Maria
    Antonioli, Manuela
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [30] Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics
    Kori, Medi
    Arga, Kazim Yalcin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (11) : 1211 - 1224